Rizatriptan dosage forms and strengths

Rizatriptan
MAXALT^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Rizatriptan
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dosage Forms and Strengths

MAXALT Tablets

5 mg tablets are pale pink, capsule-shaped, compressed tablets coded MRK on one side and 266 on the other. 10 mg tablets are pale pink, capsule-shaped, compressed tablets coded MAXALT on one side and MRK 267 on the other.

MAXALT-MLT Orally Disintegrating Tablets

5 mg orally disintegrating tablets are white to off-white, round lyophilized tablets debossed with a modified triangle on one side. 10 mg orally disintegrating tablets are white to off-white, round lyophilized tablets debossed with a modified square on one side.^[1]

References

↑ “MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.]”.

Adapted from the FDA Package Insert.

[dailymed.nlm.nih.gov-1] “MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.]”.

[1]

Rizatriptan dosage forms and strengths

Dosage Forms and Strengths

MAXALT Tablets

MAXALT-MLT Orally Disintegrating Tablets

References

Looking for the patient version?